Warning letter
Advanced Botanical Consulting & Testing Inc dba ABC Testing: warning letter of Jun 4, 2019
FDA warning letter 572991 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 572991 |
|---|---|
| Company | Advanced Botanical Consulting & Testing Inc dba ABC Testing |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Jun 4, 2019 |
| Posted date | Jun 11, 2019 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| CFR sections cited | 211.194(a), 211.165(e), 211.34, 211.68(a), 211.68(b) |
| Inspection city | Tustin |
| Inspection ZIP | 92780 |
| Inspection start date | Nov 1, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: